Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyperlipidemic xanthomas.

Journal of the American Academy of Dermatology·1989
Same author

Hypercholesterolemia: a reversible risk factor for coronary heart disease.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·1989
Same author

Primary hypertriglyceridemia.

American journal of diseases of children (1960)·1984
Same author

Multiple risk factor intervention trial.

Canadian Medical Association journal·1983
Same author

Occupational screenings: recruitment from private industry.

Circulation·1982
Same author

Probucol: a weak hypocholesterolemic agent.

Canadian Medical Association journal·1981

Related Experiment Video

Updated: Jun 4, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

Hyperlipidemia: time to treat?

M A Mishkel

    Canadian Family Physician Medecin De Famille Canadien
    |February 1, 2011
    PubMed
    Summary

    This review provides practical guidance on managing hyperlipidemia (HLD), covering screening, laboratory expectations, and treatment strategies including diet and medication. It addresses key questions for effective HLD patient care.

    Area of Science:

    • Cardiology
    • Preventive Medicine
    • Clinical Practice Guidelines

    Background:

    • Hyperlipidemia (HLD) is a significant risk factor for cardiovascular disease.
    • Effective management strategies are crucial for patient outcomes.
    • Evidence-based guidelines are essential for clinical decision-making.

    Purpose of the Study:

    • To provide a practical, evidence-based approach to hyperlipidemia management.
    • To answer fundamental questions regarding HLD screening and treatment.
    • To synthesize current knowledge from key references.

    Main Methods:

    • Review of five key references published since 1982.
    • Focus on practical aspects of hyperlipidemia management.
    • Addressing seven core questions related to screening and treatment.

    Related Experiment Videos

    Last Updated: Jun 4, 2026

    Assessing Whole-Body Lipid-Handling Capacity in Mice
    07:57

    Assessing Whole-Body Lipid-Handling Capacity in Mice

    Published on: November 24, 2020

    Main Results:

    • Detailed guidance on who, how, and when to screen for HLD.
    • Information on laboratory expectations for HLD assessment.
    • Comprehensive overview of treatment expectations and methods.
    • Description of both dietary and pharmacological interventions.

    Conclusions:

    • Effective screening and timely treatment of HLD are vital.
    • A multi-faceted approach involving lifestyle and medication is recommended.
    • This review serves as a practical resource for clinicians managing HLD.